Ledger.Open graph →
SEC Form D · filed April 15, 2022

DNAlite Therapeutics, Inc

Offering
$8.9M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Andrew C. Mcclary · Berkeley, CADirectorMubhij Ahmad · San Francisco, CAExec · DirectorDavid C. Rabuka · San Francisco, CADirectorTimothy P. Day · San Francisco, CADirectorDrew C. Lanza · San Francisco, CADirectorMubhij Ahmad · San Francisco, CAExec · DirectorDavid C. Rabuka · San Francisco, CADirectorTimothy P. Day · San Francisco, CADirectorAndrew C. Mcclary · Black Mountain, NCDirectorDrew C. Lanza · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗